| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918884 | Radiotherapy and Oncology | 2012 | 5 Pages |
Abstract
I-125 brachytherapy with 6Â months of ADT demonstrates excellent bNED rates in Gleason 7 disease. We found no evidence of a difference between patients with Gleason 3Â +Â 4 versus 4Â +Â 3 disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Christopher Herbert, W. James Morris, Mira Keyes, Jeremy Hamm, Vincent Lapointe, Michael McKenzie, Thomas Pickles, Ingrid Spadinger,